Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00286481 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia
A Phase 3 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,362
- Enrollment target
NCT00286481: Completed Phase 3 study, sponsored by Takeda.
NCT00286481 is a Phase 3 study that has completed, run by Takeda. The registered enrollment target is 1,362 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00286481, a Phase 3 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,362 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate lapaquistat acetate, once daily (QD), taken alone or with simvastatin on cholesterol levels in treating patients with elevated cholesterol.
Interventions
- DRUG Simvastatin
- DRUG Lapaquistat acetate and simvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,362 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-05 |
| Phase | Phase 3 |
What the finished NCT00286481 record still lists
NCT00286481 is an interventional study that assigns participants to a tested intervention. Its 1,362 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% higher).
The record links to 0 conditions, and to 2 interventions - of which Simvastatin is the first listed.
NCT00286481 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00286481 about?
NCT00286481 is a clinical study titled "Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia". The purpose of this study is to evaluate lapaquistat acetate, once daily (QD), taken alone or with simvastatin on cholesterol levels in treating patients with elevated cholesterol.
What is the current status of trial NCT00286481?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,362 participants. The study started on 2006-03. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00286481?
The interventions under investigation include: Simvastatin (DRUG), Lapaquistat acetate and simvastatin (DRUG).
Who is sponsoring clinical trial NCT00286481?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00286481's enrollment target sits among peer trials
1,362 180th of 2000 higher than 1,821 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02677064 · 1,365 participants
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
- NCT04489238 · 1,366 participants
Collection of Information to Better Understand Young Onset Colorectal Cancer
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
- NCT07256392 · 1,370 participants · Phase 3
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia